---
title: "Pharvaris N.v. Insider Sold Shares Worth $1,459,970, According to a Recent SEC Filing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285044723.md"
description: "Anne Lesage, Chief Early Development at Pharvaris N.v., sold 48,300 shares for $1,459,970 on April 29, 2026. Following this transaction, she controls a total of 190,419 common shares, with 56,450 shares held directly and 133,969 shares controlled indirectly, as per a recent SEC filing."
datetime: "2026-05-04T08:14:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285044723.md)
  - [en](https://longbridge.com/en/news/285044723.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285044723.md)
---

# Pharvaris N.v. Insider Sold Shares Worth $1,459,970, According to a Recent SEC Filing

04:14 AM EDT, 05/04/2026 (MT Newswires) -- Anne Lesage, Chief Early Development, on April 29, 2026, sold 48,300 shares in Pharvaris N.v. ( PHVS ) for $1,459,970. Following the Form 4 filing with the SEC, Lesage has control over a total of 190,419 common shares of the company, with 56,450 shares held directly and 133,969 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1830487/000119312526201925/xslF345X05/ownership.xml

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [PHVS.US](https://longbridge.com/en/quote/PHVS.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)

## Related News & Research

- [Relay's treatment shown to shrink vascular malformations in mid-stage trial](https://longbridge.com/en/news/286890329.md)
- [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md)
- [Wave Life Sciences posts positive RestorAATion-2 data; WVE-006 restores M-AAT, cuts Z-AAT, supports monthly dosing](https://longbridge.com/en/news/286818220.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)
- [Eton Pharmaceuticals Adds Another 2026 Launch As It Secures U.S. Rights To IMPAVIDO](https://longbridge.com/en/news/287025596.md)